Gender differences in medication adherence among adolescent and young adult kidney transplant recipients

Transplantation

Volumn 103, Issue 4, 2019, Pages 798-806

  Boucquemont, Julie ^a   Pai, Ahna L H ^b,c   Dharnidharka, Vikas R ^d,e   Hebert, Diane ^f   Furth, Susan L ^g,h   Foster, Bethany J ^a,i,j  

^a MCGILL UNIVERSITY   (Canada)

^b Center for the Promotion of Treatment Adherence and Self Management   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ST LOUIS CHILDREN S HOSPITAL   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^j MONTREAL CHILDREN S HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; AGE; ARTICLE; CANADA; CHILD; DRUG STORAGE; DRUG USE; ELECTRONIC PILLBOX; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MINIMUM PLASMA CONCENTRATION; PRESCRIPTION; PRIORITY JOURNAL; SELF REPORT; SEX DIFFERENCE; TIME; UNITED STATES; YOUNG ADULT; BLOOD; SEXUAL CHARACTERISTICS; STATISTICAL MODEL;

ADOLESCENT; AGE FACTORS; CHILD; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; SEX CHARACTERISTICS; TACROLIMUS; YOUNG ADULT;

EID: 85057961805     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000002359     Document Type: Article

References (37)

1. Kabore R Couchoud C Macher MA. Age-dependent risk of graft failure in young kidney transplant recipients. Transplantation. 2017; 101: 1327-1335.
2. Lepeytre F Dahhou M Zhang X. Association of sex with risk of kidney graft failure differs by age. J Am Soc Nephrol. 2017; 28: 3014-3023.
3. Bouman A Heineman MJ Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update. 2005; 11: 411-423.
4. Fish EN. The X-files in immunity: Sex-based differences predispose immune responses. Nat Rev Immunol. 2008; 8: 737-744.
5. Chisholm-Burns MA Spivey CA Tolley EA. Medication therapy management and adherence among US renal transplant recipients. Patient Prefer Adherence. 2016; 10: 703-709.
6. Denhaerynck K Steiger J Bock A. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant. 2007; 7: 108-116.
7. Prihodova L Nagyova I Rosenberger J. Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: A cross-sectional and prospective study. J Adv Nurs. 2014; 70: 2871-2883.
8. Spivey CA Chisholm-Burns MA Damadzadeh B. Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients. Clin Transplant. 2014; 28: 96-104.
9. Weng LC Yang YC Huang HL. Factors that determine self-reported immunosuppressant adherence in kidney transplant recipients: A correlational study. J Adv Nurs. 2017; 73: 228-239.
10. Chisholm MA Lance CE Mulloy LL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Am J Health Syst Pharm. 2005; 62: 1775-1781.
11. Marsicano EO Fernandes NS Colugnati FA. Multilevel correlates of non-adherence in kidney transplant patients benefitting from full cost coverage for immunosuppressives: A cross-sectional study. PLoS One. 2015; 10: E0138869.
12. Vlaminck H Maes B Evers G. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant. 2004; 4: 1509-1513.
13. Weng FL Israni AK Joffe MM. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol. 2005; 16: 1839-1848.
14. Dobbels F Ruppar T De Geest S. Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: A systematic review. Pediatr Transplant. 2010; 14: 603-613.
15. Chisholm-Burns MA Spivey CA Rehfeld R. Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. Am J Transplant. 2009; 9: 2497-2504.
16. Dew MA Dabbs AD Myaskovsky L. Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation. 2009; 88: 736-746.
17. De Bellis MD Keshavan MS Beers SR. Sex differences in brain maturation during childhood and adolescence. Cereb Cortex. 2001; 11: 552-557.
18. Blakemore SJ Choudhury S. Development of the adolescent brain: Implications for executive function and social cognition. J Child Psychol Psychiatry. 2006; 47: 296-312.
19. Stilley CS Lawrence K Bender A. Maturity and adherence in adolescent and young adult heart recipients. Pediatr Transplant. 2006; 10: 323-330.
20. Foster BJ Pai A Zhao H. The TAKE-IT study: Aims, design, and methods. BMC Nephrol. 2014; 15: 139.
21. Foster BJ Pai ALH Zelikovsky N. A randomized trial of a multicomponent intervention to promote medication adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT). Am J Kidney Dis. 2018; 72: 30-41.
22. Zelikovsky N Schast AP. Eliciting accurate reports of adherence in a clinical interview: Development of the Medical Adherence Measure. Pediatr Nurs. 2008; 34: 141-146.
23. Zelikovsky N Schast AP Palmer J. Perceived barriers to adherence among adolescent renal transplant candidates. Pediatr Transplant. 2008; 12: 300-308.
24. Denhaerynck K Schafer-Keller P Young J. Examining assumptions regarding valid electronic monitoring of medication therapy: Development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol. 2008; 8: 5.
25. Yang D Dalton JE. A unified approach to measuring the effect size between two groups using SAS®. SAS Global Forum 2012-statistics and data analysis 2012. Orlando, FL
26. Bernardi RA. Associations between Hofstede's Cultural Constructs and Social Desirability Response Bias. J Bus Ethics. 2006; 65: 43-53.
27. Hebert JR Clemow L Pbert L. Social desirability bias in dietary self-report may compromise the validity of dietary intake measures. Int J Epidemiol. 1995; 24: 389-398.
28. Liu H Golin CE Miller LG. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001; 134: 968-977.
29. Shemesh E Fine . Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients? Pediatr Transplant. 2010; 14: 940-943.
30. Cramer JA Scheyer RD Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990; 150: 1509-1510.
31. Kuypers DR Claes K Evenepoel P. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: A prospective study in one hundred de novo renal transplant recipients. Clin Pharmacokinet. 2004; 43: 741-762.
32. Soldin OP Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009; 48: 143-157.
33. Fadiran EO Zhang L. Harrison-Woolrych M. Effects of Sex Differences in the Pharmacokinetics of Drugs and Their Impact on the Safety of Medicines in Women. In: Medicines For Women. 2015 Cham: Springer International Publishing; 41-68.
34. Lieber SR Helcer J Shemesh E. Monitoring drug adherence. Transplant Rev (Orlando). 2015; 29: 73-77.
35. Williams A Low JK Manias E. Trials and tribulations with electronic medication adherence monitoring in kidney transplantation. Res Social Adm Pharm. 2016; 12: 794-800.
36. Lehmann A Aslani P Ahmed R. Assessing medication adherence: Options to consider. Int J Clin Pharmacol. 2014; 36: 55-69.
37. De Bleser L De Geest S Vandenbroeck S. How accurate are electronic monitoring devices? A laboratory study testing two devices to measure medication adherence. Sensors (Basel). 2010; 10: 1652-1660.